X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
paricalcitol (433) 433
humans (269) 269
index medicus (254) 254
vitamin d (199) 199
urology & nephrology (192) 192
male (168) 168
secondary hyperparathyroidism (162) 162
calcitriol (146) 146
female (144) 144
chronic kidney-disease (129) 129
middle aged (123) 123
ergocalciferols - therapeutic use (109) 109
hemodialysis (97) 97
aged (95) 95
chronic kidney disease (95) 95
animals (89) 89
alfacalcidol (85) 85
hyperparathyroidism, secondary - drug therapy (85) 85
hemodialysis-patients (82) 82
calcifediol (77) 77
parathyroid hormone - blood (74) 74
parathyroid-hormone (71) 71
adult (66) 66
hyperparathyroidism (66) 66
parathyroid hormone (66) 66
nephrology (64) 64
mortality (63) 63
treatment outcome (63) 63
calcium (62) 62
hyperparathyroidism, secondary - etiology (62) 62
ergocalciferols - pharmacology (61) 61
renal dialysis (60) 60
vitamin-d (57) 57
1,25-dihydroxyvitamin d-3 (56) 56
bone density conservation agents - therapeutic use (52) 52
chronic kidney failure (52) 52
kidney diseases (52) 52
albuminuria (51) 51
vitamin d - analogs & derivatives (51) 51
ergocalciferols - administration & dosage (50) 50
calcium - blood (49) 49
dialysis patients (46) 46
vitamin d - therapeutic use (46) 46
kidney failure, chronic - complications (45) 45
proteinuria (45) 45
cinacalcet (43) 43
inflammation (43) 43
rats (43) 43
kidney failure, chronic - therapy (42) 42
therapy (42) 42
phosphorus (41) 41
renal insufficiency, chronic - complications (41) 41
survival (41) 41
renal insufficiency, chronic - drug therapy (40) 40
calcitriol - therapeutic use (39) 39
analysis (38) 38
risk (38) 38
receptors, calcitriol - agonists (37) 37
hyperparathyroidism, secondary - blood (36) 36
pharmacology & pharmacy (36) 36
prospective studies (34) 34
stage renal-disease (34) 34
endocrinology & metabolism (33) 33
renin-angiotensin system (33) 33
transplantation (33) 33
cardiovascular-disease (32) 32
dialysis (32) 32
health aspects (32) 32
phosphorus - blood (32) 32
receptors, calcitriol - metabolism (32) 32
vascular calcification (31) 31
medicine & public health (30) 30
care and treatment (29) 29
d deficiency (29) 29
disease (29) 29
double-blind method (29) 29
bone-disease (28) 28
mortality risk (28) 28
aged, 80 and over (27) 27
dose-response relationship, drug (27) 27
mineral metabolism (27) 27
research (27) 27
risk factors (27) 27
vitamin d deficiency - drug therapy (27) 27
ergocalciferols - adverse effects (26) 26
hypertension (26) 26
mice (26) 26
biomarkers - blood (25) 25
diabetes (25) 25
randomized controlled-trial (25) 25
uremic rats (25) 25
medical research (24) 24
vitamin d receptor (24) 24
calcification (23) 23
calcitriol - pharmacology (23) 23
medicine, general & internal (23) 23
research article (23) 23
time factors (23) 23
renal dialysis - adverse effects (22) 22
vitamins - therapeutic use (22) 22
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (430) 430
Spanish (9) 9
Russian (6) 6
French (5) 5
German (3) 3
Japanese (1) 1
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 12/2017, Volume 18, Issue 12, p. 2586
Uterine fibroids (UFs) are the most common tumors of the female genital tract. The effect of UFs on the quality of life and the overall cost of treatment are... 
Leiomyoma | Uterine fibroid | Epigallocatechin gallate | Vitamin D | Paricalcitol | Pharmacology | Cabergoline | Elagolix | Aromatase inhibitors | AROMATASE INHIBITOR LETROZOLE | paricalcitol | epigallocatechin gallate | elagolix | MEDICAL-MANAGEMENT | GREEN TEA POLYPHENOLS | vitamin D | BIOCHEMISTRY & MOLECULAR BIOLOGY | CABERGOLINE DOSTINEX | aromatase inhibitors | cabergoline | VITAMIN-D DEFICIENCY | CHEMISTRY, MULTIDISCIPLINARY | uterine fibroid | pharmacology | CARDIOVASCULAR-DISEASE | LEIOMYOMA CELL-PROLIFERATION | EXTRACELLULAR-MATRIX | TRANSFORMING GROWTH FACTOR-BETA-3 | leiomyoma | Aromatase Inhibitors - administration & dosage | Ergolines - administration & dosage | Administration, Oral | Pyrimidines - administration & dosage | Humans | Catechin - administration & dosage | Ergocalciferols - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Ergolines - therapeutic use | Hydrocarbons, Fluorinated - administration & dosage | Pyrimidines - therapeutic use | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Quality of Life | Catechin - therapeutic use | Ergocalciferols - administration & dosage | Female | Vitamin D - administration & dosage | Catechin - analogs & derivatives | Hydrocarbons, Fluorinated - therapeutic use | Vitamin D - therapeutic use | Aromatase Inhibitors - therapeutic use | Genital tract | Risk groups | Prophylaxis | Epigallocatechin-3-gallate | Hysterectomy | Modulators | Quality of life | Uterus | Surgery | Aromatase | Progesterone | Tumors
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 08/2012, Volume 27, Issue 8, pp. 3270 - 3278
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 11/2019, Volume 41, Issue 11, pp. 2416 - 2423
Diabetic nephropathy (DN) is a major complication of diabetes. Paricalcitol is a vitamin D analog that is typically used for secondary hyperparathyroidism in... 
diabetic nephropathy | paricalcitol, renin-angiotensin-aldosterone system | Diabetic kidney disease | renin-angiotensin-aldosterone system | VITAMIN-D | paricalcitol | D-RECEPTOR ACTIVATION | INFLAMMATION | PROTEINURIA | PHARMACOLOGY & PHARMACY | ENDOTHELIAL FUNCTION
Journal Article
Diabetic Medicine, ISSN 0742-3071, 03/2015, Volume 32, Issue 3, pp. 374 - 381
Journal Article
JAMA, ISSN 0098-7484, 06/2012, Volume 307, Issue 21, pp. 2253 - 2253
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 2014, Volume 29, Issue 4, pp. 899 - 905
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 10/2017, Volume 18, Issue 10, p. 2057
Paricalcitol is approved for prevention and therapy of secondary hyperparathyroidism (sHPT) in patients with chronic kidney disease (CKD), with only short-term... 
Dialysis | Secondary hyperparathyroidism (sHPT) | Chronic kidney disease (CKD) | Parathormone (PTH) | Paricalcitol | Predialysis | dialysis | parathormone (PTH) | predialysis | VITAMIN-D | PHOSPHORUS | MULTICENTER | paricalcitol | INTESTINAL CALCIUM | PTH | BIOCHEMISTRY & MOLECULAR BIOLOGY | SECONDARY HYPERPARATHYROIDISM | chronic kidney disease (CKD) | CHEMISTRY, MULTIDISCIPLINARY | DIALYSIS PATIENTS | HEMODIALYSIS-PATIENTS | PARATHYROID-HORMONE | secondary hyperparathyroidism (sHPT) | CALCITRIOL | Renal Insufficiency, Chronic - etiology | Humans | Middle Aged | Renal Dialysis - methods | Ergocalciferols - therapeutic use | Male | Renal Insufficiency, Chronic - complications | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Calcium - blood | Austria | Time Factors | Aged, 80 and over | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Kidney Failure, Chronic - diagnosis | Hyperparathyroidism, Secondary - drug therapy | Kidney Failure, Chronic - drug therapy | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Phosphorus - blood | Kidney Failure, Chronic - complications | Renal Dialysis - adverse effects | Biomarkers | Aged | Hyperparathyroidism, Secondary - etiology | Germany | Therapy | Intravenous administration | Hemodialysis | Documentation | Clinical trials | Fatigue | Patients | Itching | Calcium phosphates | Calcium (blood) | Pain | Vitamin D | Kidney diseases | Hyperparathyroidism | Kidney transplantation | Chronic illnesses
Journal Article